共 50 条
- [12] Efficacy of Switching from Infliximab to Subcutaneous Golimumab in Patients with Rheumatoid Arthritis to Control Disease Activity or Adverse Events [J]. Drugs in R&D, 2017, 17 : 233 - 239
- [15] Adverse events in methotrexate-treated rheumatoid arthritis patients [J]. BRITISH JOURNAL OF RHEUMATOLOGY, 1995, 34 : 49 - 56
- [17] Immunogenicity of Infliximab Is Related to Reduction of Frequency of Infliximab Administration in Rheumatoid Arthritis and Spondyloarthritis Patients [J]. ARTHRITIS AND RHEUMATISM, 2012, 64 (10): : S211 - S211
- [19] Reactions to infliximab in patients with rheumatoid arthritis [J]. JOURNAL OF RHEUMATOLOGY, 2005, 32 (07) : 1411 - 1412